Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections
dc.contributor.author | Terroni, Barbara [UNESP] | |
dc.contributor.author | Lopes, Juliana Romano [UNESP] | |
dc.contributor.author | Chin, Chung Man [UNESP] | |
dc.contributor.author | Dos Santos, Jean Leandro [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.contributor.institution | Union of the College of the Great Lakes (UNILAGO) | |
dc.date.accessioned | 2023-07-29T16:05:40Z | |
dc.date.available | 2023-07-29T16:05:40Z | |
dc.date.issued | 2021-01-01 | |
dc.description.abstract | Infection by β-coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coron-avirus-2) alters the homeostasis of the vascular endothelium, promoting an inflammatory state which causes damage and favors the prothrombotic state. The direct viral cytotoxicity induced by the SARS-CoV-2 leads to endothelial cell death; thus, altering the vessel functions. Moreover, SARS-CoV infection induces endothelial dysfunction (ED) and reduces the levels of nitric oxide (NO); thus, aggravating the vascular injuries, which promotes thrombotic events due to an altera-tion in the homeostasis. NO is a pleiotropic molecule that induces vasodilation, regulates the immune response, inhibits platelet aggregation, and decreases the cellular adhesion to vascular en-dothelium. Moreover, NO acts directly against invasive agents, exhibiting antibacterial, antiviral, and antifungal activity. High levels of NO result in an increase in the ED, causing an inflammatory amplification that aggravates the disease through undesirable positive feedback. The objective of this review was to present and discuss the involvement of NO on ED in SARS-CoV-2 infections. This review may also highlight new perspectives for therapeutic interventions through the supple-mentation of exogenous NO. The maintenance of homeostatic NO levels could represent a useful approach in the prevention of coronavirus-induced ED. | en |
dc.description.affiliation | São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo | |
dc.description.affiliation | Advanced Research Center in Medicine School of Medicine Union of the College of the Great Lakes (UNILAGO), São Paulo | |
dc.description.affiliationUnesp | São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipId | CAPES: 001 | |
dc.description.sponsorshipId | FAPESP: 2018/11079-0 | |
dc.description.sponsorshipId | CNPq: 304731/2017-0 | |
dc.description.sponsorshipId | CNPq: 313435/2019-7 | |
dc.identifier | http://dx.doi.org/10.2174/2666796701999201230121515 | |
dc.identifier.citation | Coronaviruses, v. 2, n. 9, 2021. | |
dc.identifier.doi | 10.2174/2666796701999201230121515 | |
dc.identifier.issn | 2666-7975 | |
dc.identifier.issn | 2666-7967 | |
dc.identifier.scopus | 2-s2.0-85148026753 | |
dc.identifier.uri | http://hdl.handle.net/11449/249656 | |
dc.language.iso | eng | |
dc.relation.ispartof | Coronaviruses | |
dc.source | Scopus | |
dc.subject | COVID-19 | |
dc.subject | endothelium dysfunction | |
dc.subject | inhaled NO | |
dc.subject | nitric oxide | |
dc.subject | NO donors | |
dc.subject | SARS-COV-2 | |
dc.title | Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections | en |
dc.type | Artigo | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
unesp.department | Fármacos e Medicamentos - FCF | pt |